ArticleBMC genomics2025
Learning a refinement model for variant analysis in non-human primate genomes.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAccurate variant calling is essential for genomic studies but is highly dependent on sequence alignment (SA) quality. In non-human primates, the lack of well-curated variant resources limits alignment postprocessing, leading to suboptimal SA and increased miscalls. DeepVariant, a leading variant caller, demonstrates high accuracy in human genomes but exhibits performance degradation under suboptimal SA conditions.
resultsTo address this, we developed a decision tree-based refinement model that integrates alignment quality metrics and DeepVariant confidence scores to filter miscalls effectively. We defined suboptimal SA and optimal SA based on the presence or absence of postprocessing steps and confirmed that suboptimal SA significantly increases miscalls in both human and rhesus macaque genomes. Applying the refinement model to human suboptimal SA reduced the miscalling ratio (MR) by 52.54%, demonstrating its effectiveness. When applied to rhesus macaque genomes, the model achieved a 76.20% MR reduction, showing its potential for non-human primate studies. Alternative base ratio (ABR) analysis further revealed that the model refines homozygous SNVs more effectively than heterozygous SNVs, improving variant classification reliability.
conclusionsOur refinement model significantly improves variant calling in suboptimal SA conditions, which is particularly beneficial for non-human primate studies where alignment postprocessing is often limited. We packaged our model into the Genome Variant Refinement Pipeline (GVRP), providing for researchers working on population genetics and molecular evolution. This work establishes a framework for enhancing variant calling accuracy in species with limited genomic resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.